Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants.” A final safety review committee…
Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to advise that it has reached binding…
Cleo Diagnostics (COV:AU) has announced Appendix 4D and Half Yearly Accounts Download the PDF here. This post appeared first…
Argo Digital US has launched its 24/7 gold investment platform in the US. In an early February announcement, the…
Bitcoin is prone to price volatility, with wide swings to the upside and downside. There has been renewed interest…
News and Media The content of this article is restricted. Please login to your account in order to read…
News and Media The content of this article is restricted. Please login to your account in order to read…
(TheNewswire) The Part-and-Parcel private placement was fully subscribed and raised gross proceeds of $800,000, subject to final TSXV approval.…
The Apitipi Anicinapek Nation (AAN) has filed a lawsuit against McEwen Mining (TSX:MUX,NYSE:MUX), alleging the company has breached an…